Publications by authors named "T Sanji"

Chiral crystalline compounds of the series of [Ln(α-PWO)] polyanions embracing nearly all the lanthanide (Ln) ions were successfully isolated using Pro (proline) as a chiral director. In each compound, the polyanion and Pro were associated through a stereoselective interaction involving N(H)···O hydrogen bonding. P NMR and circular dichroism studies revealed the induction of chirality by Pro in the racemic aqueous systems of the [Ln(α-PWO)] polyanions, i.

View Article and Find Full Text PDF

We present an alternative approach to fabricating hexagonally arranged nanodot arrays of various metals by seed-mediated electroless plating with a cylinder-forming block copolymer thin film, PEO-b-PMA(Az), as a scaffold. Metal ions were selectively incorporated into PEO cylinders, followed by their reduction to metal and the etching of the scaffold to obtain highly ordered seed arrays of Au, Pd, and Pt. Nanodot arrays of the target metals (Au, Ag, and Ni) were selectively grown on the seed with their highly ordered arrangement by electroless plating.

View Article and Find Full Text PDF

A transition-metal-free controlled polymerization for the attainment of poly(-aryleneethynylene)s is developed. The polymerization of 1-pentafluorophenyl-4-[(trimethylsilyl)ethynyl]benzene with a catalytic amount of fluoride anions proceeds in a chain-growth-like manner to afford polymers with controlled molecular weights and low polydispersity indexes. The mechanism involves a pentacoordinated fluorosilicate as a key intermediate.

View Article and Find Full Text PDF

A catalytic amount of fluoride anion promoted the polymerization of 2-pentafluorophenyl-5-trimethylsilylthiophene, providing a high-molecular-weight conjugated polymer in a chain-growth-like manner. The resulting polymer with a controlled molecular weight and a low molecular weight distribution was obtained in a high yield. The mechanism involves a pentacoordinated fluorosilicate as a key intermediate.

View Article and Find Full Text PDF

Cisplatin or cis-diamminedichloroplatinum (II) (CDDP) is a cytotoxic chemotherapeutic agent with dose-dependent peripheral neuropathy as a foremost side effect characterised by ataxia, pain, and sensory impairment. Cumulative drug therapy of CDDP is known to produce severe oxidative damage. It mainly targets and accumulates in dorsal root ganglia that in turn cause damage resulting in secondary nerve fibre axonopathy.

View Article and Find Full Text PDF